The Research Progress Of The Prediction Of Cervical Cancer Neoadjuvant Chemotherapy Sensitivity

In malignant tumors of women worldwide, cervical cancer is located in the secondplace. In recent years, the number of young patients is constantly increasing，more andmore tend to be younger patients. In the treatment of cervical cancer, in addition tohow to improve the patients survival rate is important, and how to improve the patientsquality of life is also important. With the application of neoadjuvant chemotherapy inthe treatment of cervical cancer,they who have lost the chance of operation have a newhope, especially for young women,offering them retain the possibility of sexual functionand ovarian requirements. Research shows that the effective rate of neoadjuvantchemotherapy is from70%to90%.However, part of the patients of neoadjuvantchemotherapy is not sensitive,it is not only increased their economic burden, andeven delay the timing of treatment of these patients. So more and more scholars beganto study sensitive factors of cervical cancer neoadjuvant chemotherapy, hopingto predict whether a patient is sensitive to neoadjuvant chemotherapy before thetreatment，including the pathological type of cervical cancer, tumor stage, tumor size,tumor cell markers, imaging examination, etc.In the hope of provide more referenceabout the diagnosis and treatment of cervical cancer,this paper summarized the generalsituation of cervical cancer neoadjuvant chemotherapy,involving the chemotherapy,indications and contraindications, the existing problems,the significance as well as thesensitive factors.